Navigation Links
L'Oreal Paris Celebrates Ten Years of Hope and Healing

New 'Color of Hope' Jewelry Collection Donates 100% of Net Profits to The

Ovarian Cancer Research Fund

NEW YORK, Sept. 11 /PRNewswire/ -- L'Oreal Paris proudly commemorates the 10th anniversary of its partnership with The Ovarian Cancer Research Fund (OCRF) and its ongoing commitment to women's health and empowerment causes. Over the past decade, L'Oreal Paris has offered hope to the tens of thousands of women afflicted with ovarian cancer, helping raise over $13 million dollars to advance research, increase awareness and ultimately find a cure.

(Photo: )

In celebration of Ovarian Cancer Awareness Month this September, L'Oreal Paris is adding two new pieces to its Color of Hope Jewelry Collection, a fundraising campaign benefiting OCRF. The two new pieces designed exclusively for this initiative - a sterling silver Pave Pendant with Chain ($24.95 retail) and sterling silver Pave Earrings ($29.95 retail) - join the signature sterling silver Color of Hope Bracelet ($24.95 retail) and the brilliant 14k white gold & pave Diamond Bracelet ($795.00 retail) that was originally created to commemorate the glamorous and star-studded 2006 L'Oreal Legends Gala. All four pieces feature an "O"-shaped clasp that can be viewed as a circle representing life, endurance, love or a symbol for ovarian cancer. The collection is a simple way for women everywhere to visibly and tangibly help the fight against this most deadly of women's cancers. L'Oreal Paris is donating 100% of all net profits ($5.00 for each sterling silver item and $150.00 for the diamond bracelet) from the Color of Hope jewelry collection to OCRF. All of the items from the collection may be purchased online at and at L'Oreal Paris retail stores: Connecticut 860-561-0220; Los Angeles 310-360-6555.

L'Oreal Paris is fully committed to the fight against ovarian cancer and has developed several programs to raise awareness, educate women about the disease and its symptoms, and support survivors. As a multi-pronged campaign, the Color of Hope initiatives include:

- Beauty for a Cause. The L'Oreal Paris Color of Hope Makeup Collection

is every bit as inspiring, on-trend and fashion-forward as it is

hopeful. Featuring products for eyes, lips and cheeks, the collection

pairs the universally flattering shade of mauve with vibrant teal - the

color symbolizing ovarian cancer awareness. Together, these shades

represent strength, hope and inspiration. L'Oreal Paris will donate 10

percent of the retail price from each Color of Hope lipcolour purchased

to OCRF. The collection will be available at mass market retailers in

October 2007.

- Hope Begins with You. L'Oreal Paris will donate one dollar from the

sale of select skincare products to OCRF throughout October at

participating Wal-Mart stores nationwide. L'Oreal Paris will also

distribute a brand-new ovarian cancer awareness brochure that shares

the stories of several ovarian cancer survivors and provides pertinent

educational information about the disease.

- Strong Educational Programs. To promote awareness and early detection,

L'Oreal Paris created public service announcements featuring L'Oreal

Paris spokespersons Andie MacDowell and Milla Jovovich. The

announcements empower women to make educated choices regarding their

well-being and encourage them to speak to their doctors about ovarian

cancer. L'Oreal Paris also launched a dedicated website for this

campaign - The website provides information

about the disease and offers ways for people to help support the fight

against ovarian cancer.

- A Special Partnership. In September issues, Hearst Magazines will run a

half-page "bookmark" adjacent to a full page Q&A about ovarian cancer

and a photograph of each editor-in-chief of five different Hearst

women's magazines: Good Housekeeping; Harper's BAZAAR; Marie Claire;

O, The Oprah Magazine and Redbook. In an effort to raise awareness,

each magazine will encourage readers to get involved in the fight

against ovarian cancer, which affects over 22,000 new women a year in

the U.S. alone. The bookmarks introduce a "call to action" for readers

to show their support for the cause by purchasing the Color of Hope

bracelet, with net proceeds benefiting OCRF to fund life-saving


- L'Oreal Paris Ovarian Cancer Awareness Week. From September 17th

through September 21st, L'Oreal Paris will sponsor a company-wide

ovarian cancer awareness week dedicated to building awareness,

compassion and commitment among its employees. The week includes a

"Breaking the Silence Breakfast," which educates employees and

important women in their lives about the signs, symptoms and risk

factors of the disease. The company will also host a "Survivor Beauty

Festival" day of pampering at the L'Oreal Paris salon for ovarian

cancer survivors and those currently undergoing treatment. In

addition, employees will be given the opportunity to receive makeovers

by professional makeup artists using the Color of Hope Makeup


- Annual Fundraiser. This year's fundraiser, "L'Oreal Paris Presents ...

A Night of Hope," will be held in Los Angeles on November 7th. The

cocktail party and silent auction will unite famous faces from the

worlds of beauty, fashion and entertainment to raise much-needed funds

for OCRF.

Bring hope to the thousands of women and their loved ones who have been affected by this devastating disease. Join L'Oreal Paris in the fight against ovarian cancer. Hope begins with you.


The Ovarian Cancer Research Fund is the leading independent, non-profit organization in the United States dedicated to advancing research, raising awareness and finding a cure. Ovarian cancer takes the lives of over 15,000 women in the United States each year, with over 22,000 new cases being diagnosed annually. There is currently no method of early detection, leading to late diagnosis in 75 percent of all cases. OCRF is committed to funding the best and the brightest of scientific investigators whose work focuses on new tools for detection, prevention, and better treatment options. To date, the OCRF has funded 112 researchers at 41 leading cancer institutes nationwide.

Every day the Ovarian Cancer Research Fund makes a difference in the lives of thousands of women and their families. With each new grant awarded, new steps are being taken toward finding a cure. With their commitment comes hope to all. For more information, please visit


L'Oreal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L'Oreal Paris made a long-term commitment to The Ovarian Cancer Research Fund (OCRF), which continues to build. To date, L'Oreal Paris has helped raise over $13 million dollars on behalf of OCRF with fundraising efforts such as the L'Oreal Legends Gala and L'Oreal's annual "Color of Hope" bracelet and cosmetic collection.

L'Oreal Paris, a division of L'Oreal USA, Inc. is a total beauty care company that combines the latest in technology with the highest in quality for the ultimate in luxury beauty at mass. The L'Oreal Paris product family includes Couleur Experte, Preference, Excellence Creme, Feria, and ColorSpa Moisture Actif haircolors; Studio Line styling products, the VIVE line of shampoos and conditioners, the L'Oreal Kids grooming line, Dermo-Expertise skincare, the Body Expertise body care line and L'Oreal Paris Color Cosmetics.

SOURCE L'Oreal Paris
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Comparison between warfarin and aspirin
2. Clinical Comparisons Between ADHD Drugs Are Less
3. Differences in brain pattern among liars and cheats in comparison to honest people
4. Disney in Trouble? Negative Excitement in Disneyland, Paris
5. Primary Health Care Parishioners of Second Largest HIV Infected Area in US Fail to Offer HIV Tests
6. Bistronomy is Conquering Dining in Paris
7. 45 Day Jail Sentence for Paris Hilton
8. Paris is Out of the Medical Ward and Back in the Slammer
9. Paris Sex Tape Comes Back to Haunt Her in the Slammer
10. Paris medical Condition is a Sexually Transmitted Infection
11. Paris Hilton Turns to the Virgin Mary to Save Her from the Slammer
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... of workshops to discuss bioavailability and the need to integrate dose form selection ... in collaboration with OBN, the membership organization supporting and bringing together the UK’s ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... PRMA Plastic ... November 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , ... wake up every day excited to rebuild lives and it’s an honor to have ...
(Date:11/26/2015)... ... November 26, 2015 , ... Pixel Film Studios brings Final ... ProTrailer: Vintage. This newly styled ProTrailer pack comes with 30 all-new vintage-inspired designs, ... giving users limitless opportunities to stylize and create designs quickly and easily, all ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of the ... to improve system efficiency and reliability. , The new Q-Suite 6 platform is based ... system avoids locking itself into a specific piece of software for many key components ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... the addition of the  "2016 Future ... European Therapeutic Drug Monitoring (TDM) Market: ... Intelligence, Emerging Opportunities"  report to their ... has announced the addition of the  ...
(Date:11/26/2015)... , November 26, 2015 ... of the "Radioimmunoassay Market by Type ... Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application ... Forecast to 2020" report to their ... announced the addition of the "Radioimmunoassay ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
Breaking Medicine Technology: